Company Analysis

Nexalin Technology, Inc. (NXL)

Nasdaq: NXL · Electromedical & Electrotherapeutic Apparatus · Houston, TX · filing with the SEC since 2011
Grade3.7
◀ Past 3.0● Present 2.5▶ Future 6.0
2 est.

Who runs Nexalin Technology, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
White Mark
CEO. First filing Sep 2022, latest Dec 23, 2025, 3 filings in all.
Officers reporting now
5
of 7 people with a filing in the last fifteen months
Directors reporting now
2
9 people on the record since 2022
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
White MarkCEOSep 2022Dec 23, 2025none
Van Fleet JustinCFOAug 2025Dec 23, 2025none
Owens DavidChief Medical OfficerSep 2022Dec 23, 2025none
Shelton Carolyn HambySr. VP - Quality - RegulatoryFeb 2025Dec 23, 2025none
Elson MarilynMs. Elson serves as CFOSep 2022Sep 30, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Hu BendirectorSep 2022Dec 23, 2025none
Kazden AlandirectorSep 2022Dec 23, 2025none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Osser Leonard10% ownerSep 2022Sep 30, 2025none
Earlier names on the record2, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton NXL · research, not advice